Information Provided By: 
Fly News Breaks for February 1, 2016
WLK, AXLL
Feb 1, 2016 | 06:44 EDT
JPMorgan analyst Jeffrey Zekauskas upgraded Axiall (AXLL) to Overweight saying the company would fit well with Westlake Chemical (WLK). It is reasonable to think that Westlake will raise its bid for Axiall, Zekauskas tells investors in a research note after the company's $20 per share offer got rejected. The possibility of Westlake proposing a management slate in a proxy filing could provide incentives for negotiation, he contends. Zekauskas raised his price target for Axiall to $25 from $20. Citi this morning downgraded the stock to Neutral.
News For AXLL;WLK From the Last 2 Days
There are no results for your query AXLL;WLK
